Inhaled nitric oxide in the neonatal period

Bibliography

• VOSATKA RJ, KASHYAP S, TRIFILETTI RR: Argininedeficiency accompanies persistent pulmonary hypertension of the newborn. Biol. Neonate (1994) 66:65–70.
   PubMedGoogle Scholar
• KAVVADIA V, GREENOUGH A, LILLEY J et al: Plasmaarginine levels and the response to inhaled nitric oxide in neonates. Biol. Neonate (1999) 76:340–347.
   PubMedGoogle Scholar
• CHRISTOU H, ADATIA I, VAN MARTER LJ et al: Effect of inhaled nitric oxide on endothelin-1 and cyclic guanosine 5'-monophophate plasma concentrations in newborn infants with persistent pulmonary hypertension. J Pediatr. (1997) 130(4):603–611.
   PubMed Web of Science ®Google Scholar
• FROSTELL C: Nitric oxide inhalation - future drug or an invitation to disaster? Paediatr. Anaesth. (1994) 4:147–150.
   Google Scholar
• SHAH N, JACOB T, EXLER R et al.: Inhaled nitric oxide incongenital diaphragmatic hernia. J. Pediatr. Surg. (1994) 29:1010–1015.
   PubMed Web of Science ®Google Scholar
• ROA J-C, STORME L, ZUPAN V, MORVILLE P, DINH-XUAN AT, MERCIER J-C: Echocardiographic investigation of inhaled nitric oxide in newborn babies with severe hypoxaemia. Lancet (1994) 344:303–305.
   PubMed Web of Science ®Google Scholar
• ROBERTS JDJ, POLANER DM, LANG P, ZAPOL WM: Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet (1992) 340:818–819.
   PubMed Web of Science ®Google Scholar
• LONNQVIST PA, WINBERG P, LUNDELL B, SELLDEN H,OLSSON GL: Inhaled nitric oxide in neonates and children with pulmonary hypertension. Acta Paediatr. (1994) 83:1132–1136.
   PubMed Web of Science ®Google Scholar
• PARKER TA, KINSELLA JP, ABMAN SH: Response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn: relationship to baseline oxygenation. J. Perinatol. (1998) 18(3):221–225.
   PubMedGoogle Scholar
• GOLDMAN AP, TASKER RC, HAWORTH SG, SIGSTON PE, MACRAE DJ: Four patterns of response to inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics (1996) 98:706–713.
   PubMed Web of Science ®Google Scholar
• DAY RW, LYNCH JM, WHITE KS, WARD RM: Acute response to inhaled nitric oxide in newborns with respiratory failure and pulmonary hypertension. Pediatrics (1996) 98:698–705.
   PubMed Web of Science ®Google Scholar
• BIBAN P, TREVISANUTO D, PETTENAZZO A, FERRARESEP, BARALDI E, ZACCHELLO F: Inhaled nitric oxide in hypoxaemic newborns who are candidates for extracorporeal life support. Eur. Respir. J. (1998) 11:371–376.
   PubMed Web of Science ®Google Scholar
• STEINHORN RH, COX PN, FINEMAN JR et al: Inhalednitric oxide enhances oxygenation but not survival in infants with alveolar capillary dysplasia. J. Pediatr. (1997) 130(3):417–422.
   PubMed Web of Science ®Google Scholar
• LAUBSCHER B, GREENOUGH A, KAVVADIA V, DEVANE SP: Response to nitric oxide in term and preterm infants. Eur. j Pediatr. (1997) 156:639–642.
   PubMed Web of Science ®Google Scholar
• VAN MEURS KP, RHINE WD, ASSELIN JM, DURAND DJ, AND THE PREEMIE NO COLLABORATIVE GROUP: Response of premature infants with severe respira-tory failure to inhaled nitric oxide. Pediatr. Pulmonol (1997) 24(5):319–323.
   PubMed Web of Science ®Google Scholar
• PELIOWSKI A, FINER NN, ETCHES PC, TIERNEY AJ, RYANCA: Inhaled nitric oxide for premature infants after prolonged rupture of the membranes. J. Pediatr. (1995) 126:450–453.
   PubMed Web of Science ®Google Scholar
• BANKS BA, SERI I, ISCHIROPOULOS H, MERRILL J,RYCHIK J, BALLARD RA: Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia. Pediatrics (1999) 103:610–618.
   PubMed Web of Science ®Google Scholar
• THOMPSON MW, BATES JN, KLEIN JM: Treatment of respiratory failure in an infant with bronchopul-monary dysplasia infected with respiratory syncytial virus using inhaled nitric oxide and high frequency ventilation. Acta Paediatr. (1995) 84:100–102.
   PubMed Web of Science ®Google Scholar
• HIRANI WM, SHANON DC, KACMAREK R, HURFORD WE, ZAPOL WM: Inhaled nitric oxide in infants and children with bronchopulmonary dysplasia. Am. J. Respir. Grit. Care Med. (1996) 153:A499.
   PubMed Web of Science ®Google Scholar
• BLAND R, COULTON D, ALBERTINE K et al: Pulmonary vascular effects of nitric oxide and cGMP in preterm lambs with chronic injury. FASEB J (1998) 12:A645.
   Web of Science ®Google Scholar
• KINSELLA JP, NEISH SR, IVY DD, SHAFFER E, ABMAN SH: Clinical response to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J. Pediatr. (1993) 123:103–108.
   PubMed Web of Science ®Google Scholar
• FINER NN, ETCHES PC, KAMSTRA B, TIERNEY AJ,PELIOWSKI A, RYAN A: Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. J. Pediatr. (1994) 124:302–308.
   PubMed Web of Science ®Google Scholar
• CLARK RH, KUESER TJ, WALKER MW et al: Low-dosenitric oxide therapy for persistent pulmonary hypertension of the newborn. N Engl. J. Med. (2000) 342 (7):469–474.
   PubMed Web of Science ®Google Scholar
• WOOD KS, MCCAFFREY MJ, DONOVAN JC, STILES AD,BOSE CL: Effect of initial nitric oxide concentration on outcome in infants with persistent pulmonary hypertension of the newborn. Biol. Neonate (1999) 75 (4):215–224.
   PubMedGoogle Scholar
• DAVIDSON D, BAREFIELD ES, KATTWINKEL J et al.:Inhaled nitric oxide for the early treatment of persis-tent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. Pediatrics (1998) 101:325–334.
   PubMed Web of Science ®Google Scholar
• CORNFIELD DN, MAYNARD RC, DE-REGNIER R-AO et al:Randomized controlled trial of low dose inhaled nitric oxide in the treatment of term and near-term infants with respiratory failure and pulmonary hypertension. Pediatrics (1999) 104:1089–1094.
   PubMed Web of Science ®Google Scholar
• SKIMMING JW, BENDER KA, HUTCHISON AA, DRUMMOND WH: Nitric oxide inhalation in infants with respiratory distress syndrome. J. Pediatr. (1997) 130:225–230.
   PubMed Web of Science ®Google Scholar
• FINER NN, BARRINGTON KJ: Nitric oxide for respiratoryfailure in infants born at or near term (Cochrane review). In: The Cochrane Library. Update Software (1999).
   Google Scholar
• THE NEONATAL INHALED NITRIC OXIDE STUDY GROUP:Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl. J. Med. (1997) 336:597-604. (Erratum appears N Engl. J. Med. (1997) 337:434).
   Google Scholar
• KINSELLA JP, TRUOG WE, WALSH WF et al.: Randomized,multicenter trial of inhaled nitric oxide and high frequency oscillatory ventilation in severe persistent pulmonary hypertension of the newborn. J. Pediatr. (1997) 131:55–62.
   PubMed Web of Science ®Google Scholar
• THE NEONATAL INHALED NITRIC OXIDE STUDY GROUP(NINOS): Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. Pediatrics (1997) 99(6):838–845.
   PubMed Web of Science ®Google Scholar
• ROBERTS JD, FINEMAN JR, MORIN FC et al.: Inhaled nitricoxide and persistent pulmonary hypertension of the newborn. N Engl. J. Med. (1997) 336:605–610.
   PubMed Web of Science ®Google Scholar
• WESSEL DL, ADATIA I, VAN MARTER LJ et al. Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics (1997) 100 (5):E7.
   Google Scholar
• BAREFIELD ES, KARLE VA, PHILIPS JB, CARLO WA:Inhaled nitric oxide in term infants with hypoxemic respiratory failure. J. Pediatr. (1996) 129:279–286.
   PubMed Web of Science ®Google Scholar
• THE FRANCO-BELGIUM COLLABORATIVE NO TRIAL GROUP: Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomised controlled trial. Lancet (1999) 354:1066–1071.
   PubMed Web of Science ®Google Scholar
• KINSELLA JP, PARKER TA, GALAN H, SHENDAN BC, HALBOWER AC, ABMAN SH: Effect of iN0 on pulmonary oedema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Pediatr. Res. (1997) 41:457–463.
   PubMed Web of Science ®Google Scholar
• SUBHEDAR NV, RYAN SW, SHAW NJ: Open randomizedcontrolled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants. Arch. Dis. Child. (1997) 77:F185–F190.
   Web of Science ®Google Scholar
• KINSELLA JP, WALSH WF, BOSE CL et al.: Inhaled nitricoxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial. Lancet (1999) 354:1061–1065.
   PubMed Web of Science ®Google Scholar
• DAVIDSON D, BAREFIELD ES, KATTWINKEL J etal.: Safetyof withdrawing inhaled nitric oxide therapy in persis-tent pulmonary hypertension of the newborn. Pediat-rics (1999) 14(2):231–236.
   Google Scholar
• FRAMPTON MW, MORROW PE, COX C, GIBB FR, SPEERSDM, UTELL MJ: Effects of nitrogen dioxide exposure on pulmonary function and airway reactivity in normal humans. Am. Rev. Respir. Dis. (1991) 143:522–527.
   PubMed Web of Science ®Google Scholar
• DOBYNS EL, GRIEBEL J, KINSELLA JP, ABMAN SH,ACCURSO FJ: Infant lung function after inhaled nitric oxide therapy for persistent pulmonary hypertension of the newborn. Pediatr. Pulmonol. (1999) 28:24–30.
   PubMed Web of Science ®Google Scholar
• SCOTT EM, HOSKINDS DD: Hereditary methaemo-globinaemia in Alaskans, Eskimos and Indians. Blood (1958) 13:795–802.
   PubMed Web of Science ®Google Scholar
• HALLMAN M, BRY K: Nitric oxide and lung surfactant.Semin. Perinatol. (1996) 20:173–185.
   PubMed Web of Science ®Google Scholar
• ISSA A, LAPPALAINEN U, KLEINMAN M, BRY K, HALLMANM: Inhaled nitric oxide decreases hyperoxia-induced surfactant abnormality in preterm rabbits. Pediatr. Res. (1999) 45(2):247–254.
   PubMed Web of Science ®Google Scholar
• ARROYO PL, HATCH-PIGOTT V, MOWER HF, COONEYRV: Mutagenicity of nitric oxide and its inhibition by antioxidants. Mutat. Res. (1992) 281:193–202.
   PubMed Web of Science ®Google Scholar
• ISOMURA K, CHIKAHIRA M, TERANISHI K, HAMADA K:Induction of mutations and chromosome aberrations in lung cells following in vivo exposure of rats to nitrogen oxides. Mutat. Res. (1984) 136:119–125.
   PubMed Web of Science ®Google Scholar
• MONCADA S, PALMER RMJ, HIGGS EA: Nitric oxide:physiology, pathophysiology and pharmacology. Pharmacol. Rev. (1991) 43:109–142.
   PubMed Web of Science ®Google Scholar
• GEORGE TN, JOHNSON KJ, BATES JN, SEGAR JL: Theeffect of inhaled nitric oxide therapy on bleeding time and platelet aggregation in neonates. J. Pediatr. (1998) 132:731–734.
   PubMed Web of Science ®Google Scholar
• CHRISTOU H, MAGNANI B, MORSE DS et al: Inhaled nitric oxide does not affect adenosine 5'-diphosphate-dependent platelet activation in infants with persis-tent pulmonary hypertension of the newborn. Pediat-rics (1998) 102:1390–1393.
   PubMed Web of Science ®Google Scholar
• HOGMAN M, FROSTELL C, ARNBERG H, HEDENSTIERNA G: Bleeding time prolongation and NO inhalation. Lancet (1993) 341:1664–1665.
   PubMed Web of Science ®Google Scholar
• CHEUNG P-Y, PELIOWSKI A, ROBERTSON CMT: The outcome of very low birthweight neonates 1500 g) rescued by inhaled nitric oxide: neurodevelopment in early childhood. J. Pediatr. (1998) 133:735–739.
   PubMed Web of Science ®Google Scholar
• SUBHEDAR NV, SHAW NJ: Changes in oyxgenation andpulmonary haemodynamics in preterm infants treated with inhaled nitric oxide. Arch. Dis. Child. (1997) 77:F191–F197.
   Web of Science ®Google Scholar
• ROSENBERG AA, KENNAUGH JM, MORELAND SG et al: Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension. J. Pediatr. (1997) 131(1):70–75.
   PubMed Web of Science ®Google Scholar
• DIMITRIOU G, GREENOUGH A, KAVVADIA V, DEVANE SP, RENNIE JM: Outcome predictors in nitric oxide treated preterm infants. Eur. J. Pediatr. (1999) 158:589–591.
   PubMed Web of Science ®Google Scholar
• MERCIER JC, ZUPAN V, DELIAN M, RENANDIN MH, BONCHET M, RAVEAU C: Device to monitor concentra-tion of inhaled nitric oxide. Lancet (1993) 342:431–432.
   PubMed Web of Science ®Google Scholar